Verona Pharma plc (VRNA) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Blavatnik Len 55,911,648 주 보유. 기타 주요 보유자에는 Access Industries Holdings LLC 및 ZACCARDELLI DAVID.
지난 12개월간 내부자는 40 건의 거래를 수행 VRNA 주식 — 16 건 매수 (평가액 $431.64K) 및 15 건 매도 (평가액 $26.87M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.
VRNA 내부자 보유 현황
최대 보유자
Blavatnik Len
55,911,648 주
매수 (12개월)
16
$431.64K 평가액
내부자 주요 보유자
| # |
이름 |
직책 |
보유 주식수 |
최종 신고일 |
상대적 규모 |
| 1 |
Blavatnik Len |
Director |
55,911,648 |
2022-08-17 |
|
| 2 |
Access Industries Holdings Llc |
10 Percent Owner |
51,111,648 |
2022-08-17 |
|
| 3 |
Zaccardelli David |
President and CEO |
13,190,168 |
2025-06-13 |
|
| 4 |
Hahn Mark W |
Chief Financial Officer |
12,278,992 |
2025-06-13 |
|
| 5 |
Makhzoumi Mohamad |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 6 |
Florence Anthony A. Jr. |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 7 |
Sandell Scott D |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 8 |
Baskett Forest |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 9 |
Makower Joshua |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 10 |
Sonsini Peter W. |
10 Percent Owner |
9,757,393 |
2021-01-04 |
|
| 11 |
Orbimed Advisors Llc |
Director |
4,180,691 |
2023-05-15 |
|
| 12 |
Gupta Rishi |
Director |
4,180,691 |
2023-05-15 |
|
| 13 |
Rickard Kathleen A. |
Chief Medical Officer |
2,546,472 |
2025-05-08 |
|
| 14 |
Poll Claire |
General Counsel |
1,176,920 |
2024-02-05 |
|
| 15 |
Fisher Andrew |
General Counsel |
439,999 |
2025-06-18 |
|
| 16 |
Edwards Martin |
Director |
96,000 |
2025-04-29 |
|
| 17 |
Cunningham Kenneth |
Director |
96,000 |
2025-04-29 |
|
| 18 |
Ullman Anders |
Director |
96,000 |
2025-04-29 |
|
| 19 |
Ebsworth David R |
Director |
96,000 |
2025-04-29 |
|
| 20 |
Brady James Aloysius |
Director |
96,000 |
2025-04-29 |
|
최근 거래 (최근 12개월)
| 날짜 |
이름 |
직책 |
유형 |
주식수 |
주가 |
금액 |
| 2025-06-16 |
Fisher Andrew |
General Counsel |
정보 매도 |
80,000 |
$11.53 |
$922K |
| 2025-05-15 |
Fisher Andrew |
General Counsel |
옵션 행사 |
80,000 |
$2.01 |
$160.9K |
| 2025-06-11 |
Zaccardelli David |
President and CEO |
정보 매도 |
400,000 |
$11.40 |
$4.56M |
| 2025-06-11 |
Hahn Mark W |
Chief Financial Officer |
정보 매도 |
400,000 |
$11.40 |
$4.56M |
| 2025-05-29 |
Zaccardelli David |
President and CEO |
정보 매도 |
208,696 |
$9.33 |
$1.95M |
| 2025-05-28 |
Zaccardelli David |
President and CEO |
정보 매도 |
157,704 |
$9.30 |
$1.47M |
| 2025-05-27 |
Zaccardelli David |
President and CEO |
정보 매도 |
33,600 |
$9.53 |
$320.18K |
| 2025-05-29 |
Hahn Mark W |
Chief Financial Officer |
정보 매도 |
204,864 |
$9.33 |
$1.91M |
| 2025-05-28 |
Hahn Mark W |
Chief Financial Officer |
정보 매도 |
162,704 |
$9.30 |
$1.51M |
| 2025-05-27 |
Hahn Mark W |
Chief Financial Officer |
정보 매도 |
32,432 |
$9.53 |
$308.98K |
| 2025-05-20 |
Sinha Vikas |
Director |
옵션 행사 (매도) |
160,000 |
$0.50 |
$80.61K |
| 2025-04-29 |
Sinha Vikas |
Director |
옵션 행사 (매도) |
120,384 |
$1.70 |
$204.65K |
| 2025-05-15 |
Fisher Andrew |
General Counsel |
정보 매도 |
80,000 |
$8.57 |
$685.6K |
| 2025-05-14 |
Ackermann Christina |
Director |
정보 매도 |
40,000 |
$8.44 |
$337.6K |
| 2025-05-06 |
Rickard Kathleen A. |
Chief Medical Officer |
정보 매도 |
114,984 |
$8.82 |
$1.01M |
| 2025-05-01 |
Rickard Kathleen A. |
Chief Medical Officer |
옵션 행사 (매도) |
50,000 |
- |
- |
| 2025-05-02 |
Zaccardelli David |
President and CEO |
정보 매도 |
400,000 |
$9.09 |
$3.64M |
| 2025-05-01 |
Zaccardelli David |
President and CEO |
옵션 행사 (매도) |
200,000 |
- |
- |
| 2025-05-02 |
Hahn Mark W |
Chief Financial Officer |
정보 매도 |
400,000 |
$9.09 |
$3.64M |
| 2025-05-01 |
Hahn Mark W |
Chief Financial Officer |
옵션 행사 (매도) |
200,000 |
- |
- |
| 2025-05-01 |
Ebsworth David R |
Director |
옵션 행사 |
140,000 |
$1.93 |
$270.73K |
| 2025-04-29 |
Fisher Andrew |
General Counsel |
옵션 행사 (매도) |
86,064 |
- |
- |
| 2025-03-19 |
Fisher Andrew |
General Counsel |
증여 (수령) |
1 |
- |
- |
| 2025-04-29 |
Rickard Kathleen A. |
Chief Medical Officer |
옵션 행사 (매도) |
86,064 |
- |
- |
| 2024-08-07 |
Rickard Kathleen A. |
Chief Medical Officer |
RSU 부여 |
300,000 |
- |
- |
